Intellectual disability and epilepsy: the clinical relationship
Intellectual disability and epilepsy frequently occur together because some developmental conditions affect both the formation of cognitive and adaptive abilities and the brain networks involved in seizures. Intellectual disability involves significant limitations in intellectual functioning and adaptive behavior arising during the developmental period. Epilepsy is a brain condition characterized by an enduring predisposition to epileptic seizures, diagnosed using clinical criteria that take recurrence risk and epilepsy syndromes into account. A person can have either condition alone, both conditions, or epilepsy associated with a developmental disorder that has a more complex course. Their coexistence requires an integrated assessment of seizures, health, communication, learning, participation, and the support the individual wants and needs. AAIDD criteria; ILAE clinical definition.
The practical question is how epilepsy influences a person's developmental trajectory and everyday life, and how clinicians and support networks can identify and treat seizures while preserving agency, communication, education, employment, relationships, and meaningful activity. Answers depend on the cause of both conditions, seizure type and frequency, associated medical problems, medication effects, the person's baseline strengths, and the quality of the environment. Clinical decisions must therefore be individualized rather than inferred from an intelligence score, a diagnostic label, or a single seizure description. NICE epilepsy guideline; AAIDD criteria.
What intellectual disability means in this context
A comprehensive intellectual disability assessment evaluates both intellectual functioning, such as reasoning and learning, and adaptive functioning, such as conceptual, social, and practical skills used in everyday situations. AAIDD's current definition places origin before age 22 and emphasizes culturally valid assessment, recognition of strengths, and individualized supports. The individual's support needs are contextual and change with development, illness, assistive technology, and environmental accessibility. A seizure diagnosis cannot by itself establish intellectual disability, and a history of delayed speech or school difficulties is insufficient to determine the diagnosis. AAIDD criteria.
The clinical implications of epilepsy are better understood against a person's prior baseline: communication methods, ability to interpret instructions, mobility, sleep, self-care, coping strategies, relationships, and patterns of alertness. A person who becomes less communicative after a seizure may be experiencing a transient postictal state; a child showing sustained developmental regression needs an assessment of the broader neurological and medical situation. Establishing the baseline prevents clinicians from mistaking a new medical problem for an unchanging attribute of intellectual disability. NICE mental health guideline; NICE epilepsy guideline.
What qualifies as epilepsy
The International League Against Epilepsy's practical clinical definition recognizes epilepsy after two unprovoked or reflex seizures more than 24 hours apart, after one such seizure when the estimated ten-year recurrence risk is sufficiently high, or when an epilepsy syndrome is diagnosed. A seizure is an event; an epilepsy diagnosis requires assessment of the enduring tendency toward seizures and its cause. Provoked acute symptomatic events, fainting, sleep phenomena, movement disorders, and other episodic changes require their own evaluation. Fisher and colleagues, 2014.
The 2025 ILAE seizure classification organizes seizures into focal, generalized, unknown whether focal or generalized, and unclassified groups. It distinguishes biological classification from observed descriptors and recognizes that awareness, responsiveness, behavior, movements, and autonomic signs can vary. This matters for people whose language or motor abilities make ordinary seizure descriptions incomplete. The event should be characterized as precisely as possible without assuming that every unusual movement or episode of reduced interaction is epileptic. Beniczky and colleagues, 2025.
How frequently do intellectual disability and epilepsy coexist?
A systematic review by Robertson and colleagues pooled general samples of people with intellectual disabilities and estimated epilepsy prevalence at 22.2%, with a 95% confidence interval of 19.6% to 25.1%. The review included studies with differing populations, definitions, ascertainment strategies, and severity distributions; its summary therefore describes the historical evidence base rather than a universal probability for every person or region. The review found higher prevalence with greater severity of intellectual disability. The study's separate estimate for Down syndrome reflects that population and should not be generalized across all genetic diagnoses. Robertson and colleagues, 2015.
Prevalence estimates also differ according to the age of participants, associated cerebral palsy or genetic disorders, whether participants live in community or institutional settings, and whether epilepsy has been clinically verified. People with severe or profound intellectual disability and complex neurological conditions are overrepresented in some clinical cohorts. Conversely, community samples may miss unrecognized episodes, particularly where access to neurological assessment or adequate communication support is limited. Group statistics help services plan expertise and resources; they do not predict an individual person's seizures, learning potential, or future independence. Robertson and colleagues, 2015.
Shared developmental causes and mechanisms
Genetic and structural causes
The overlap between epilepsy and intellectual disability often reflects a common underlying developmental cause. Pathogenic genetic variants can affect neuronal migration, synaptic signaling, ion channels, and the establishment of brain networks; chromosomal conditions may also influence both cognition and seizure susceptibility. Structural abnormalities of cortical development, previous central nervous system injury, certain metabolic diseases, and acquired brain insults can produce combined cognitive and seizure-related phenotypes. The diagnostic question is whether a recognized cause explains both conditions and changes counseling, surveillance, or treatment. ILAE classification framework; ILAE neonatal and infant epilepsy syndromes.
Genes associated with epilepsy exhibit variable expression. Individuals with variants in the same gene can have substantially different seizure burdens and developmental profiles, including cases with comparatively preserved intellectual function. Etiologic descriptions therefore require individual interpretation, family history, neurological examination, electroclinical evidence, and genetic results where clinically indicated. A reported genetic variant is meaningful only after evaluation of pathogenicity and consistency with the person's presentation. The presence of a genetic diagnosis should not replace a careful appraisal of treatable contributors to distress or changing function. Scheffer and colleagues, 2017.
Developmental and epileptic encephalopathy
Developmental and epileptic encephalopathy is a clinical concept used when both the underlying disorder and epileptic activity contribute to developmental impairment. In some syndromes the pathogenic process independently compromises development, while frequent seizures or epileptiform discharges impose additional adverse effects on cognition and behavior. The relative contributions can be difficult to separate, and an individual's course may change with age. The concept is particularly relevant to selected early-onset epilepsies and does not describe everyone who has both epilepsy and intellectual disability. Scheffer and colleagues, 2017; ILAE infant syndromes, 2022.
Clinically, this framework explains why evaluating developmental stagnation or loss of previously acquired skills requires more than attributing the changes to an intellectual disability diagnosis. The neurological team may need to review seizure recurrence, electroencephalographic patterns, sleep-related epileptiform activity, medication effects, and possible underlying causes. Some improvements in seizure control can support better alertness or participation, while established developmental limitations may persist. Reducing seizures and maximizing developmental opportunity remain distinct outcome goals and should each be measured. Scheffer and colleagues, 2017.
Interaction over time
The relationship is dynamic. Seizures may interrupt sleep, school attendance, concentration, mobility, and participation in routines. Recovery periods can affect attention and short-term functioning. Repeated hospitalization or restrictions imposed out of fear may further reduce access to education, recreation, and social experience. At the same time, communication difficulties can impede the reporting of auras, adverse effects, pain, or emotional changes. These bidirectional influences are best understood in a developmental and ecological model that follows the person's abilities and opportunities over time rather than treating one assessment as a permanent forecast. NICE epilepsy guideline; World Health Organization ICF.
Recognizing seizures when communication differs
Epileptic events can involve staring, abrupt behavioral arrest, impaired responsiveness, unusual sensations, sudden falls, tonic stiffening, jerks, autonomic changes, or convulsions. A person may be unable to describe internal sensations, and witnesses may interpret events through expectations based on the person's disability. Seizure recognition should therefore begin with careful description: the first observable change, body position, responsiveness, movement sequence, duration, breathing, skin color, recovery, sleep relation, and consistency across repeated episodes. The 2025 ILAE classification supports structured descriptions that retain the chronological sequence of observable signs. Beniczky and colleagues, 2025.
Caregivers and staff may notice subtle differences in the person's customary interaction: a familiar response is absent, coordinated movements stop, facial expression changes, or a previously reliable communication signal temporarily disappears. Video recordings of typical events, obtained safely and with appropriate consent, can help a neurologist interpret semiology. An incident diary can record time, context, possible triggers, duration, recovery, injuries, and rescue medication use. The goal is an interpretable clinical history, not surveillance that diminishes privacy or autonomy. NICE epilepsy guideline.
Distinguishing seizures from other episodes
Seizure-like events have a broad differential diagnosis. Syncope and cardiovascular problems may cause sudden collapse; sleep disorders can produce unusual nocturnal behaviors; migraine, movement disorders, medication effects, panic, dissociation, and sensory or behavioral events may resemble seizures. Stereotyped movements or repetitive behaviors may be mistaken for epilepsy, while focal or subtle nonconvulsive seizures may be missed when staff presume a person is simply distracted. These possibilities can coexist, making the assessment of each recurring episode essential. ILAE clinical definition; NICE epilepsy guideline.
A change in behavior should never be interpreted automatically as either a seizure or a psychiatric symptom. Pain, constipation, infection, dehydration, menstrual symptoms, adverse medication effects, trauma, anxiety, loss of sleep, and changes in routine can produce distress. Conversely, sudden stereotyped changes with altered responsiveness deserve neurological review. A functional understanding of behavior and a medical assessment can proceed together; neither substitutes for the other. NICE challenging behavior guideline; NICE mental health guideline.
Clinical evaluation and diagnostic reasoning
A coordinated history and examination
A clinically sound evaluation combines the individual's account in their preferred communication mode with information from knowledgeable supporters and prior records. It reconstructs developmental milestones, seizure onset, event patterns, family history, previous neurological conditions, medications, adaptive skills, prior educational assessments, and changes in health or function. Direct engagement with the person remains central even when relatives or paid supporters provide supplementary information. Accessible language, pictures, communication devices, adequate appointment time, and supported decision-making improve the quality of the history. NICE information and support; AAIDD defining criteria.
Assessment should identify the question each investigation can answer. A developmental or adaptive behavior assessment establishes strengths, support needs, and the impact of cognitive limitations, while neurological assessment investigates the clinical nature of episodic events and their cause. Cognitive testing may require adaptation for motor, sensory, language, or attentional differences. Diagnosis of intellectual disability uses converging information about intellectual and adaptive function across settings and during the developmental period. Epilepsy cannot be diagnosed by an IQ test, and intellectual disability cannot be determined from an EEG. AAIDD criteria; ILAE classification.
Electroencephalography, imaging, and genetic investigation
An EEG can support characterization of seizure type and epilepsy syndrome when interpreted with clinical history; a normal routine EEG does not rule out epilepsy and an incidental epileptiform pattern does not automatically explain every unusual behavior. Sleep or prolonged video EEG may be considered by specialists when events remain uncertain. Brain imaging and genetic or metabolic investigations depend on clinical presentation, age at onset, examination, and the potential for findings to inform treatment. Results must be interpreted within a coherent clinical formulation rather than treated as isolated labels. NICE epilepsy guideline; ILAE infant syndromes, 2022.
People with intellectual disability may need sensory adjustments, procedural preparation, familiar supporters, and alternatives to unnecessarily distressing investigations. The practical cost of testing includes anxiety, travel, sedation risks where applicable, and interruption of routine. Shared planning should explain anticipated benefits and burdens, consent or appropriate authorization, and how the result would change decisions. Accommodations are part of diagnostic quality because investigations that a person cannot tolerate or understand may yield less useful information. NICE information and support.
Developmental regression and urgent changes
New loss of acquired communication, walking ability, awareness, self-care, or sustained alertness warrants timely medical review. The differential includes ongoing epileptic activity, prolonged postictal phenomena, new medication toxicity, infection, metabolic or structural illness, depression, pain, and other causes. A person with prolonged or repeated seizures without adequate recovery may need emergency care under an individualized seizure action plan. Sudden regression is not a routine feature to accept without investigation solely because intellectual disability is already documented. NICE epilepsy guideline; CDC seizure first aid.
Treatment of epilepsy within the whole-person care plan
Choosing and reviewing antiseizure treatment
Epilepsy treatment seeks to reduce seizures, prevent injury and emergency events, and preserve tolerability, cognition, mood, sleep, and quality of life. Medication choice depends on seizure classification, epilepsy syndrome, etiology, interactions, comorbidity, pregnancy-related risks, and personal preferences. Intellectual disability alone is not a medication selection algorithm. Prescribers should establish a baseline for attention, communication, behavior, sleep, mobility, and daily activities so that changes after treatment can be assessed with the person and their supporters. NICE principles of treatment.
Potential adverse effects include sedation, dizziness, impaired coordination, fatigue, changes in appetite or sleep, and behavioral or mood changes. Risks vary by drug, dose, combination, and individual susceptibility; evidence from selected epilepsy syndromes should not be extrapolated indiscriminately to every person with intellectual disability. A targeted review of developmental and epileptic encephalopathies documents neurobehavioral and cognitive adverse events associated with antiseizure medications and the need for individualized interpretation. People who have difficulty describing subjective symptoms may communicate adverse effects through reduced engagement, irritability, changes in mobility, or altered sleep. Review of antiseizure medication effects.
Medication monitoring should ask both whether seizures improved and what treatment changed in the person's life. A simple seizure count cannot capture injuries, nighttime disruption, missed activities, communication, emotional well-being, or caregiver burden. When several medications are used, clinicians should review interactions, dosing, adherence difficulties, cumulative adverse effects, and the possibility that changes reflect illness rather than medication. Antiseizure drugs should not be abruptly stopped or adjusted by unqualified supporters; any change needs the treating prescriber's plan. NICE epilepsy guideline.
Drug-resistant epilepsy and specialist options
Persistent seizures despite appropriately chosen and tolerated treatments require reassessment of diagnosis, adherence barriers, syndrome classification, and possible referral to specialist epilepsy services. For selected individuals, specialist evaluation may consider surgery, neurostimulation, dietary approaches, or syndrome-specific therapies. Eligibility and expected benefit depend on the epilepsy itself, not simply on whether the person has intellectual disability. The evidence for advanced treatments is heterogeneous across etiologies and functional outcomes, and a seizure response does not guarantee parallel improvement in every cognitive or behavioral domain. NICE epilepsy guideline.
Treatment deliberations should include practical considerations: the ability to communicate discomfort, management of devices or dietary regimens, accessibility of postoperative and follow-up care, and whether the person and supporters can maintain treatment safely. A multidisciplinary team may include neurology, developmental or intellectual disability medicine, nursing, psychology, dietetics, pharmacy, rehabilitation, and social care. The person's goals remain a central part of determining what counts as a meaningful treatment outcome. NICE information and support.
Seizure safety, emergency planning, and preventable harm
Individualized seizure action plans
An individualized plan should identify the person's usual seizure presentation, expected recovery, everyday safety precautions, criteria for giving prescribed rescue medication, when to seek urgent assistance, and who is responsible in home, school, work, or supported living settings. The plan should be written in accessible language, reviewed after changes in seizure patterns or treatment, and shared with consent across relevant services. NICE recommends up-to-date, agreed comprehensive epilepsy care plans shaped by individual needs and discussed with the person and relevant supporters. NICE epilepsy care planning.
First aid emphasizes staying with the person, clearing hazards, timing the event, protecting the head, positioning safely where appropriate, and allowing recovery. Never restrain convulsive movements or place objects in the person's mouth. Emergency services are warranted when a convulsive seizure lasts longer than five minutes, another seizure follows without adequate recovery, breathing or waking is difficult, injury occurs, the seizure occurs in water, or a first seizure is suspected. The person's clinician may give a more specific emergency threshold or rescue protocol; local emergency numbers differ by country. CDC seizure first aid.
Injury risk, status epilepticus, and SUDEP
Repeated convulsions, falls, swimming or bathing hazards, prolonged seizures, and disrupted supervision arrangements can create preventable risk. Safety measures should be tailored to actual seizure features, not imposed uniformly. Practical interventions might involve safe bathing arrangements, appropriate supervision around water, first-aid training, adequate sleep support, or access to a reliable emergency communication method. Managing risk requires balancing protection with mobility, privacy, recreation, personal preference, and the right to participate in ordinary life. NICE epilepsy guideline; CDC seizure first aid.
Sudden unexpected death in epilepsy, or SUDEP, is a rare but serious epilepsy-related risk that warrants an individualized, respectful discussion. Risk is not the same for all people; clinicians consider seizure type, especially uncontrolled convulsive seizures, and other relevant factors. Earlier literature reviews have found associations between intellectual disability and SUDEP in some studies, although inconsistent definitions and confounding limit attribution to intellectual disability as an independent causal factor. Transparent discussion should lead to concrete risk-reduction and seizure-control planning instead of either alarm or silence. SUDEP and intellectual disability review; NICE monitoring and safety.
NICE recommends regular monitoring reviews, at least annually, for adults with epilepsy who have a learning disability, as well as for several other higher-risk groups. More frequent assessment may be appropriate for persistent seizures, new adverse effects, or changing health. The review should cover the person's experience, seizure control, safety, medications, comorbidities, and support across settings rather than turning into a mechanical prescription renewal. NICE monitoring recommendation.
Cognition, adaptive behavior, and everyday functioning
Attention, learning, and communication
People with both intellectual disability and epilepsy may experience different combinations of baseline cognitive limitations, episodic seizure-related interruptions, sleep disturbance, and medication-associated effects. Assessments that follow a seizure or occur during pronounced fatigue may underestimate usual performance. A useful longitudinal picture distinguishes stable developmental characteristics from new or fluctuating changes and documents both measured ability and the conditions under which a person demonstrates that ability. AAIDD criteria; ILAE epilepsy classification.
Communication support may include clear language, additional processing time, visual schedules, sign or symbol systems, and augmentative and alternative communication as indicated. These methods help a person report possible warning sensations, pain, fatigue, medication effects, fears, and preferences. A written care plan that only staff can read is incomplete for someone who can meaningfully participate through another communication format. Coordinated speech-language and psychological assessment can support participation in decisions about medical appointments and daily activity. NICE information and support; AAIDD criteria.
Conceptual, social, and practical adaptive skills
Conceptual skills include communication, functional literacy, planning, and understanding schedules; social skills include relationships, self-advocacy, and interpreting situations; practical skills include self-care, travel, safety, medication routines, and work tasks. Epilepsy may affect these domains through interruptions, fatigue, treatment burden, and environmental constraints. Support planning should specify where a person already functions independently, where assistance reduces risk, and which new skills or accommodations could increase participation. AAIDD criteria.
For example, a person may manage travel on familiar routes but need a tailored strategy for responding to a warning symptom; another person may independently communicate a seizure event through a device but need help managing medication schedules. These examples illustrate person-environment fit rather than universal prescriptions. Outcome measures can include completed routines, attendance, chosen activities, confidence, participation, and the person's own report of satisfaction, alongside medically measured seizures. World Health Organization ICF.
School, work, and community participation
An educational support plan may combine consistent seizure first aid with access to teaching, reasonable recovery periods, communication accommodations, and avoidance of unnecessary exclusion from activities. Adolescents and adults can similarly benefit from clear workplace procedures, tailored disclosure preferences, medication review, and practical accommodations. Everyone involved should understand the person's actual seizure features without assuming incapacity from a diagnostic label. The ethical and functional goal is sustained opportunity to learn, form relationships, work where desired, and make decisions with appropriate support. NICE epilepsy information and support; WHO ICF.
Psychological health, distress, and behavior
Epilepsy and intellectual disability may coexist with anxiety, depression, sleep problems, trauma-related symptoms, and other mental health conditions. Communication differences can alter how distress is expressed, while repeated unpredictable seizures may affect confidence, sleep, and willingness to enter community settings. Psychological assessment should use accessible interviews, collateral information, behavioral observations, changes from baseline, and appropriate tools where valid. A mental health diagnosis requires its own clinical evaluation; epilepsy, intellectual disability, or challenging behavior alone does not establish one. NICE mental health guideline.
Diagnostic overshadowing occurs when clinicians attribute new pain, emotional changes, behavioral changes, or cognitive deterioration to a known disability and consequently miss a co-occurring condition. A worsening behavior pattern could reflect seizures, postictal confusion, drug adverse effects, sleep deprivation, pain, depression, a coercive environment, or more than one factor. When clinicians compare timing with medication changes and seizure events while also evaluating environmental circumstances, they can prevent unnecessary psychiatric labeling and delayed medical care. NICE challenging behavior guideline; NICE mental health guideline.
Behavior support should reflect medical findings and functional assessment. A person who resists medication may be experiencing swallowing difficulties, taste aversion, adverse effects, fear, communication barriers, or limited choice. Support can include accessible explanations, examination for pain, discussion with the prescriber, routines developed collaboratively, and appropriate communication systems. Sedating or antipsychotic medication should not be used merely to suppress an unexplained behavior attributed to epilepsy. Medication for a separately diagnosed psychiatric or behavioral indication follows its own guideline and specialist monitoring. NICE challenging behavior guideline.
Family support, supported decisions, and coordinated services
Families and paid supporters frequently notice changes in seizure presentation, alertness, mood, and daily functioning before these changes become visible during brief clinic visits. Their observations are clinically valuable; the person with intellectual disability remains the primary subject of care and an active participant to the extent possible. Professionals can use supported decision-making, communication aids, explanations at an appropriate level, and sufficient time to establish preferences. Clinical responsibility, legal consent arrangements, and the person's rights must be addressed according to applicable law and capacity procedures. NICE information and support; United Nations CRPD.
A coherent service plan assigns responsibilities across neurology, primary care, developmental or intellectual disability services, psychiatry and psychology when indicated, education, social care, and community organizations. It specifies who tracks seizures, who reviews adverse effects, who maintains the rescue plan, and how emerging concerns are communicated. Consistent records help distinguish a change in neurological status from a change in daily support. Fragmented care can leave families repeatedly reconstructing the history and can result in contradictory recommendations across settings. NICE epilepsy care planning.
Respite, practical training, clear emergency procedures, and attention to supporter well-being help sustain care without assuming that the person's autonomy must be reduced. Staff turnover and transition between services are particular points of risk when seizure descriptions, medication instructions, or accessible communication methods are lost. A transferable plan should include concise clinical facts and the person's preferred way of being supported; detailed health information should be shared only with legitimate recipients and appropriate safeguards. NICE challenging behavior guideline.
The life-course perspective
Childhood and adolescence
In childhood, developmental surveillance, early support, and epilepsy investigation should evolve together. Some children already have recognized intellectual limitations before seizures emerge; for others, epilepsy is one sign of an underlying syndrome under investigation. Developmental trajectories are heterogeneous. Decisions about education and communication need repeated review because learning potential, independence, seizure management, and social preferences change with age. Transitions to adolescent services should include both epilepsy expertise and continuity of developmental supports. ILAE infant syndromes, 2022; NICE epilepsy guideline.
Adulthood
Adults may encounter gaps in specialist neurological services, difficulties accessing routine prevention and sexual or reproductive health care, changes in housing or paid support, and increased responsibility for medication. Epilepsy and intellectual disability services should collaborate rather than sending individuals between specialties. Adults who can make decisions with adapted information must have meaningful opportunities to do so; adults needing more extensive support should receive individualized processes that respect preferences and legal rights. NICE epilepsy guideline; AAIDD criteria.
Aging and changing baseline
With aging, clinicians should reassess seizure characteristics, falls, medication effects, cognition, sensory loss, and possible neurodegenerative processes. A change in functioning may have several competing explanations, including epilepsy-related factors, medication burden, dementia, depression, or an acute medical illness. Certain etiologic groups have distinctive age-related risks, so syndrome-specific evidence should guide assessment when relevant. Documentation of longstanding abilities and recent change is crucial for accurate differential diagnosis. NICE epilepsy guideline; WHO ICF.
Measuring meaningful outcomes and interpreting evidence
The evidence base varies substantially by research question. Systematic reviews provide informative pooled estimates of epilepsy prevalence, although sample recruitment and diagnostic definitions contribute uncertainty. ILAE classification documents establish professional terminology and diagnostic frameworks through evidence review and consensus; they do not estimate the benefit of a particular intervention for every person with intellectual disability. NICE guidance integrates available studies with clinical interpretation and service considerations. These distinct forms of evidence should not be treated as equivalent to individual randomized trials of treatments. Robertson and colleagues, 2015; Beniczky and colleagues, 2025; NICE epilepsy guideline.
Strongly established principles include distinguishing seizures from their mimics, using neurologically appropriate antiseizure treatment, developing a clear safety plan, and assessing intellectual and adaptive functioning separately. Evidence about individual neurobehavioral medication effects is clinically important but varies across drugs and populations. More limited or contested questions include the size of independent intellectual disability effects on SUDEP after accounting for seizure severity, the extent to which seizure reduction changes long-term intellectual outcomes in particular syndromes, and which combinations of community supports best improve subjective quality of life. SUDEP review; antiseizure medication review.
Trials of antiseizure interventions commonly emphasize seizure frequency, whereas families and people with intellectual disability may also prioritize alertness, comfort, communication, autonomy, sleep, and participation. Researchers and clinicians should describe adverse events, medication changes, dropout, comorbidities, and the degree to which self-report was possible. Future-independent interpretation of any study depends on knowing whose experiences and outcomes were measured. People with more complex disabilities and communication needs should be represented in research with methods appropriate to their circumstances. World Health Organization ICF; NICE information and support.
Practical clinical questions
Does epilepsy cause intellectual disability?
Epilepsy and intellectual disability often share a developmental cause. In selected developmental and epileptic encephalopathies, sustained epileptic activity can also contribute to cognitive or behavioral impairment. A causal explanation requires knowledge of the underlying condition, developmental chronology, and electroclinical course; the mere coexistence of two diagnoses does not establish that seizures caused the intellectual limitations. Scheffer and colleagues, 2017.
Can seizure control improve learning and daily functioning?
Better seizure control can reduce interruptions, injuries, recovery periods, and anxiety about unexpected events; some individuals also gain alertness or opportunities for learning. The size and durability of developmental benefit depend on underlying causes, prior functioning, medication tolerability, and educational support. Clinicians should measure both seizure outcomes and functional goals rather than promising generalized cognitive recovery. NICE epilepsy guideline.
Is every behavioral change a seizure?
No. Sudden repeated changes in consciousness or stereotyped movement deserve neurological evaluation, but pain, emotional distress, sleep loss, adverse drug effects, and environmental factors can also alter behavior. The appropriate response is to reconstruct the episode and assess competing explanations; uncertain events may require specialist evaluation. Beniczky and colleagues, 2025; NICE challenging behavior guideline.
Does a diagnosis of intellectual disability change epilepsy first aid?
Immediate first-aid principles remain centered on safety, timing, airway protection where appropriate, and emergency criteria. The individual's plan should additionally specify accessible communication, their usual recovery pattern, prescribed rescue medication, and practical adjustments for mobility or other health needs. Supporters should be trained for the actual person and setting. CDC seizure first aid; NICE care planning.
Who should coordinate care?
Coordination should be explicit and proportionate to complexity. A primary clinician or nominated care coordinator can connect neurology, other specialists, school or employment support, and home services, with the person and appropriate supporters participating in decisions. Medication responsibility, seizure emergency arrangements, follow-up schedules, and health information sharing should be recorded and reviewed. NICE epilepsy guideline.
Integrative conclusion
The clinically meaningful relationship between intellectual disability and epilepsy lies in their shared neurodevelopmental mechanisms, the possibility of additional effects from seizures and treatments, and the daily conditions under which a person learns, communicates, remains safe, and participates in life. Effective care examines seizure biology and adaptive functioning together, while preserving the independent diagnostic criteria of each condition. It is built on a reliable history, precise seizure characterization, accessible assessment, individualized treatment, planned responses to emergencies, attention to mental and physical health, and coordinated supports across the life course. The central measure of success extends from seizure control to sustained opportunities for health, choice, relationships, and participation. ILAE classification; AAIDD criteria; NICE epilepsy guideline.
Related Articles
Causes of Intellectual Disability: Genetic, Prenatal, and Developmental Factors — the etiologic framework for developmental conditions that may also confer seizure susceptibility.
Communication Difficulties in Intellectual Disability: Language, Understanding, and Support — accessible communication and participation in clinical decisions.
Diagnostic Overshadowing in Intellectual Disability: How Conditions Are Missed — recognizing new physical, neurological, and psychological conditions rather than attributing change to disability.
Mental Health Problems in People With Intellectual Disability: Recognition and Care — integrated psychological evaluation and treatment.
Fetal Alcohol Spectrum Disorders and Intellectual Functioning: Assessment and Support — Intellectual and adaptive functioning in FASD rather than broad prenatal exposure guidance.
Intellectual Disability and Cerebral Palsy: Cognition, Mobility, and Communication — Differentiate motor disability from intellectual disability in co-occurring presentations.
References
American Association on Intellectual and Developmental Disabilities. (2021). Defining criteria for intellectual disability. AAIDD.
Beniczky, S., Trinka, E., Wirrell, E., et al. (2025). Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy. Epilepsia, 66(6), 1804–1823.
Centers for Disease Control and Prevention. (2024). First aid for seizures. CDC.
Fisher, R. S., Acevedo, C., Arzimanoglou, A., et al. (2014). ILAE official report: A practical clinical definition of epilepsy. Epilepsia, 55(4), 475–482.
National Institute for Health and Care Excellence. (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges (NG11). NICE.
National Institute for Health and Care Excellence. (2016). Mental health problems in people with learning disabilities: Prevention, assessment and management (NG54). NICE.
National Institute for Health and Care Excellence. (2022; updated 2025). Epilepsies in children, young people and adults (NG217). NICE.
National Institute for Health and Care Excellence. (2023). Epilepsies in children, young people and adults: Epilepsy care plan (QS211). NICE.
Robertson, J., Hatton, C., Emerson, E., and Baines, S. (2015). Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure, 29, 46–62.
Scheffer, I. E., Berkovic, S., Capovilla, G., et al. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512–521.
Strzelczyk, A., and Schubert-Bast, S. (2022). Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs, 36, 1079–1111.
United Nations. (2006). Convention on the Rights of Persons with Disabilities. United Nations.
World Health Organization. (2001). International classification of functioning, disability and health. WHO.
Young, C., Shankar, R., Palmer, J., et al. (2015). Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk?. Seizure, 25, 112–116.
Zuberi, S. M., Wirrell, E., Yozawitz, E., et al. (2022). ILAE classification and definition of epilepsy syndromes with onset in neonates and infants. Epilepsia, 63(6), 1349–1397.